Fisher Scientific International
CGMP Chemicals in Bioproduction Processes
Pages
2
Time to read
3 mins
Publication
Language
English
Pages
2
Time to read
3 mins
Publication
Language
English
This guide discusses the importance of current good manufacturing practices (CGMP) in drug manufacturing, particularly in the context of bioproduction. It outlines how CGMP ensures the production of chemicals and raw materials under strict quality controls, which is crucial for maintaining drug quality and consistency. The document highlights a study indicating that only about half of biopharmaceutical developers utilize CGMP chemicals in early-stage clinical trials, which can lead to significant risks when nonconforming raw materials are introduced. The guide emphasizes the advantages of adopting CGMP chemicals earlier in the drug development process to facilitate smoother transitions from research to clinical production. It also addresses the challenges posed by rising competition for raw materials and the importance of establishing reliable supplier relationships. Furthermore, it discusses how planning for compliance and quality standards can minimize costs and complexities in the production workflow, ultimately aiding in the creation of new medicines.